These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 12614450
1. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B. Clin Exp Allergy; 2003 Mar; 33(3):351-8. PubMed ID: 12614450 [Abstract] [Full Text] [Related]
2. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B. Allergy Asthma Proc; 2002 Mar; 23(6):391-8. PubMed ID: 12528605 [Abstract] [Full Text] [Related]
3. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group. Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303 [Abstract] [Full Text] [Related]
4. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis. Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM. Allergy Asthma Proc; 2014 May; 35(4):338-45. PubMed ID: 24992553 [Abstract] [Full Text] [Related]
5. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. Segall N, Gawchik S, Georges G, Haeusler JM. Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116 [Abstract] [Full Text] [Related]
6. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. Meltzer EO, Weiler JM, Widlitz MD. J Allergy Clin Immunol; 1996 Feb; 97(2):617-26. PubMed ID: 8621847 [Abstract] [Full Text] [Related]
7. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734 [Abstract] [Full Text] [Related]
9. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B. Allergy Asthma Proc; 2004 Nov; 25(1):59-68. PubMed ID: 15055564 [Abstract] [Full Text] [Related]
10. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J. Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719 [Abstract] [Full Text] [Related]
14. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO. Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145 [Abstract] [Full Text] [Related]
15. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423 [Abstract] [Full Text] [Related]